DateTypeShareholderTitleTransaction TypeShare PriceSharesValue Mar 10, 2023SaleGreg MeyersEVP, Chief Digital & Tech Off.Derivative/Non-derivative$65.71 PER SHARE-1,243$-81,678 Mar 10, 2023PurchaseGreg MeyersEVP, Chief Digital & Tech Off.$0.00 PER SHARE92$0 ...
11:30aBarron'sBerkshire Stock Hits Record After Earnings Beat. Analysts Lift Price Targets. 11:29aMarket winners can fall hard — as investors in these favorite stocks found out 11:24aAlibaba’s stock falls on expensive AI-investment pledge ...
Therefore, the Zacks rating upgrade for Bristol Myers basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. Most Powerful Force Impacting Stock Prices The change in a company's future earnings potential, as reflected in ...
price and our guidance reflects that. But keep in mind, those are short-term impacts. And the long term, which is what we're focused on, we feel good about the progression that we're making on the new product portfolio. And then as we discussed just in the last question, we have an...
Price to Cash Flow (P/CF)5.40 P/FCF Ratio5.70 Enterprise Value/Market Cap1.23 Enterprise Value/Revenue3.13 Enterprise Value/Gross Profit4.33 Enterprise Value/Ebitda32.65 Forecast 1Y Price Target$61.80 Price Target Upside3.57% Upside Rating ConsensusHold Number of Analyst Covering16Show more Bristol-...
Current: 1.54 During thepast 13 years,Bristol-Myers Squibb Co'shighestAltman Z-Score was6.65. Thelowestwas1.26. And themedianwas3.14. Bristol-Myers Squibb Co Altman Z-Score Historical Data The historical data trend forBristol-Myers Squibb Co's Altman Z-Score can be seen below: ...
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.Underperform Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).Underp...
Price To Book 7.06 X Price To Sales 2.46 X Revenue 45.01 B Gross Profit 35.99 B EBITDA 19.42 B Net Income 8.04 B Cash And Equivalents 9.12 B Cash Per Share 6.21 X Total Debt 41.46 B Debt To Equity 1.32 % Current Ratio 1.42 X Book Value Per Share 8.45 X Cash Flow From Operations 13...
Johnson & Johnson has an analyst consensus of Moderate Buy, with a price target consensus of $178.58, implying a 13.6% upside from current levels. In a report issued on October 4, RBC Capital also initiated coverage with a Buy rating on the stock with a $178.00 price targ...
balance scorecard bsc balance sheet bank dr balance sheet change balance sheet price balance study balance system of pum balance weight clip balance-account funds balance-of-stores sys balanceavailablefromp balanced addition balanced armature ear balanced connecting r balanced control surf balanced force ...